- Report
- February 2024
- 80 Pages
Germany
From €1334EUR$1,500USD£1,159GBP
- Report
- February 2024
- 80 Pages
India
From €1334EUR$1,500USD£1,159GBP
- Report
- February 2024
- 80 Pages
Saudi Arabia
From €1334EUR$1,500USD£1,159GBP
- Report
- February 2024
- 80 Pages
South Korea
From €1334EUR$1,500USD£1,159GBP
- Report
- February 2024
- 80 Pages
United States
From €1334EUR$1,500USD£1,159GBP
- Report
- July 2024
Global
From €3425EUR$3,850USD£2,975GBP
€4314EUR$4,850USD£3,748GBP
- Report
- August 2021
- 121 Pages
Global
From €3202EUR$3,600USD£2,782GBP
- Report
- February 2024
- 100 Pages
Africa
From €1779EUR$2,000USD£1,546GBP
- Report
- February 2024
- 80 Pages
Poland
From €1334EUR$1,500USD£1,159GBP
- Report
- February 2024
- 80 Pages
Russia
From €1334EUR$1,500USD£1,159GBP
- Report
- October 2024
- 78 Pages
Global
From €3500EUR$4,215USD£3,147GBP
- Report
- October 2024
- 86 Pages
Global
From €3500EUR$4,215USD£3,147GBP
- Report
- April 2024
- 132 Pages
Global
From €845EUR$950USD£734GBP
- Book
- October 2019
North America
- Book
- October 2018
- 252 Pages

Parenteral Nutrition (PN) is a form of nutrition that is administered intravenously, bypassing the digestive system. It is used to provide essential nutrients to patients who are unable to consume food or absorb nutrients from the gastrointestinal tract. PN is used in a variety of healthcare settings, including hospitals, long-term care facilities, and home care. It is often used to treat patients with chronic illnesses, such as cancer, HIV/AIDS, and kidney failure.
Healthcare services related to PN include the provision of specialized equipment, such as pumps and catheters, as well as the administration of the nutrition itself. Healthcare providers also provide education and support to patients and their families to ensure that the PN is administered safely and effectively.
Companies in the PN market include Baxter International, B. Braun Melsungen AG, Fresenius Kabi, Hospira, and Nestle Health Science. Show Less Read more